152 related articles for article (PubMed ID: 2281920)
1. [Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
Brichard SM; Santoni JP; Thomas JR; Van de Voorde K; Ketelslegers JM; Lambert AE
Ann Cardiol Angeiol (Paris); 1990 Oct; 39(8):495-9. PubMed ID: 2281920
[TBL] [Abstract][Full Text] [Related]
2. Renal function, glycemic control and perindopril in diabetic patients.
Brichard S; Ketelslegers JM; Lambert AE
Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
[TBL] [Abstract][Full Text] [Related]
3. Renal function, glycaemic control and perindopril in diabetic patients.
Brichard S; Ketelslegers JM; Lambert AE
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():57-61. PubMed ID: 2505714
[TBL] [Abstract][Full Text] [Related]
4. Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
Brichard SM; Santoni JP; Thomas JR; van de Voorde K; Ketelslegers JM; Lambert AE
Diabete Metab; 1990; 16(1):30-6. PubMed ID: 2185055
[TBL] [Abstract][Full Text] [Related]
5. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
6. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
Cooper ME
J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
[TBL] [Abstract][Full Text] [Related]
7. Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
Hermans MP; Brichard SM; Colin I; Borgies P; Ketelslegers JM; Lambert AE
Am J Med; 1992 Apr; 92(4B):102S-107S. PubMed ID: 1580274
[TBL] [Abstract][Full Text] [Related]
8. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
[TBL] [Abstract][Full Text] [Related]
9. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
10. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
11. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
Marre M; Garcia Puig J; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Pozza G; Chastang C; Ollivier JP; Amouyel P; Asmar R
J Hypertens Suppl; 2003 Mar; 21(1):S19-24. PubMed ID: 12769163
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
Bönner G; Lederle RM; Scholze J; Stumpe KO
Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441
[TBL] [Abstract][Full Text] [Related]
13. A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.
Kopf D; Schmitz H; Beyer J; Frank M; Bockisch A; Lehnert H
Diabetes Nutr Metab; 2001 Oct; 14(5):245-52. PubMed ID: 11806464
[TBL] [Abstract][Full Text] [Related]
14. [Action of trandolapril on the blood glucose balance and microalbuminuria in hypertensive diabetics].
Bauduceau B; Vaur L; Rezvani Y; Gautier D
Ann Cardiol Angeiol (Paris); 1994 Feb; 43(2):84-8. PubMed ID: 8172483
[TBL] [Abstract][Full Text] [Related]
15. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
[TBL] [Abstract][Full Text] [Related]
16. Long-term tolerance of perindopril in hypertensive patients with impaired renal function.
Dratwa M; Sennesael J; Taillard F; Baguet F; Suc JM; Lins RL; Lameire N
J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S40-4. PubMed ID: 1725201
[TBL] [Abstract][Full Text] [Related]
17. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
BMJ; 1991 Jan; 302(6770):210-6. PubMed ID: 1998761
[TBL] [Abstract][Full Text] [Related]
18. [Effect of enalapril on microalbuminuria and lipid profile of normotensive type I diabetes mellitus patients].
Hernández Mijares A; Barberá Comes G; Lluch Verdú I; Morillas Ariño C; Real Collado J; Lorente Calvo R; González Bayo E; Carmena Rodríguez R
Rev Clin Esp; 1996 Jun; 196(6):354-8. PubMed ID: 8767069
[TBL] [Abstract][Full Text] [Related]
19. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
Ravid M; Lang R; Rachmani R; Lishner M
Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
[TBL] [Abstract][Full Text] [Related]
20. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
